Thyroid and antithyroid drugs

32,817 views 26 slides Oct 09, 2015
Slide 1
Slide 1 of 26
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26

About This Presentation

Lecture Classes for BNS 1st Year
Maharajgunj Nursing Campus


Slide Content

Thyroid and Antithyroid Drugs For BNS I st Year Dr. Pravin Prasad I st Year Resident, MD Clinical Pharmacology Maharajgunj Medical Campus 4 th October , 2015( Asoj 17, 2072); Sunday

Thyroid hormones: Introduction Hormone Source Remarks Triiodothyroxine T 3 Thyroid follicles Referred as thyroid hormones Tetraiodothyroxine , T 4 , Also known as thyroxine Calcitonin Parafollicular C cells Considered along with Parathormone Regulates Calcium metabolism

Thyroid Hormones: Introduction Ref: http ://biology.clc.uc.edu/fankhauser/Labs/Anatomy_&_Physiology/A&P202/Endocrine_System/histology_jpgs/thyroid_400x_P2252255lbd.JPG

Thyroid Hormone: Synthesis Membrane Bound Membrane Bound TSH

Thyroid Hormone: Synthesis Iodide Uptake Oxidation and Iodination Coupling Storage and release Peripheral conversion of T 4 to T 3

Thyroid Hormone: Transport Avidly bound to plasma proteins; 0.03%-0.08% T 4 & 0.2-0.5% T 3 in free form Bound to 3 plasma proteins: Thyroxine Binding Globulin (TBG) Thyroxine Binding prealbumin (trans- thyretin ) Albumin Plasma bound Iodine: mostly is thyroid hormone (90-95% T 4 ) Normal Concentration of PBI = 4-10mcg/dl (0.1-0.2 T 3 )

Thyroid Hormone : Metabolism and Excretion Metabolic inactivation occurs by deiodination and glucuronide /sulphate conjugation Primary site: Liver, others: salivary glands, kidney Excreted in bile  undergoes deconjugation  significant enterohepatic circulation  finally excreted in urine.

Thyroid Hormones: Regulation of Secretion

Thyroid Hormones: Actions Normal Hyperthyroidism Hypothyroidism/Deficiency States Intermediary Metabolism Lipid: indirectly enhances lipolysis; elevated plasma free fatty acid; Lipogenesis also stimulated Hypercholesterolemia Carbohydrate: metabolism stimulated; tissue utilization of sugar increased; glycogenolysis and gluconeogenesis increased, faster absorption of glucose from intestine Hyperglycaemia, diabetic like stale, insulin resistance Protein: overall catabolic, prolong action: negative nitrogen balance and tissue wasting. Weight loss

Normal Hyperthyroidism Hypothyroidism/Deficiency states Calorigenesis Increase BMR; Metabolic rates in brain, gonads, uterus, spleen, lymph nodes, not significantly affected. Cardiovascular System Hyperdynamic state of circulation due: increased peripheral demand, direct cardiac actions. Fast bounding pulse Atrial fibrillation, arrhythmias Congestive Heart Failure, angina Reduced Myocardial O 2 demand Nervous System Profound functional effects Anxious, nervous, excitable, tremors, hyperreflexia Mental Retardation (Cretinism) Sluggishness, behavioural symptoms ( Myxedema ) Skeletal Muscle Increased Muscle tone, tremor, weakness due to myopathy Flabby and weak ( Myxedema ) Gastrointestinal Increases propulsive activity Diarrhoea Constipation Thyroid Hormones: Actions

Normal Hyperthyroidism Hypothyroidism/Deficiency State Reproduction Indirect effect on Reproduction Maintenance of pregnancy and lactation Impaired female fertility Oligomenorrhoea Kidney No diuresis in euthyroid patients Diuresis in myxedematous pts on treatment with T 3 & T 4 Hematopoiesis Facilitates erythropoiesis Anaemia Growth and Development Maturation of nervous system Congenital deficiency leading to Cretinism Delayed developmental milestones Retardation and nervous deficit Adult: Impaired intelligence and slow movements Thyroid Hormones: Actions

Thyroid Hormone Receptors TR α and TR β Tissue distribution varies

Thyroid Hormones Mechanism of Action: Penetrates cells by active transport  binds to nuclear thyroid hormone receptor bound to the thyroid hormone response element (TRE) conformation changes occur ( heterodimerization of receptor with retinoid X receptor (RXR))  releases coreporessor and binding of coactivator occurs  gene transcription induced  production of specific mRNA and protein synthesis  metabolic and anatomic effects. Sensitization of adrenergic receptors to catecholamines  tachycardia, arrhythmia, raised BP, tremor, hypoglycaemia

Thyroid Hormones: Uses Cretinism Adult Hypothyroidism Myxoedema coma Nontoxic Goiter Thyroid Nodule Papillary carcinoma of thyroid Emperical use

Anti-thyroid Drugs

Classification Inhibits Hormone synthesis Propylthiouracil , Methimazole , Carbimazole Inhibits iodine trapping (ionic inhibitors) Thicynates , Perchlorates, Nitrates Inhibits hormone release Iodine, Iodides of Na and K, Organic Iodide Destroy Thyroid Tissue Radioactive iodine ( 131 I, 125 I, 123 I)

Antithyroid Drugs Mechanism of Action: Binds to the Thyroid Peroxidase and prevent oxidation of iodide/ iodotyrosil residues thereby: Inhibit iodination of tyrosine residues in thyroglobulin Inhibit coupling of iodotyrosine residues to for T 3 and T 4 Thyroid colloid is depleted over time and blood levels of thyroid hormones are progressively lowered. Additionally for Propylthiouracil : inhibits peripheral conversion of T4 to T3 by Deiodinase (D1)

Thioamides : Pharmacokinetics Well absorbed orally Widely distributed (enters milk and placenta) Higher concentration in thyroid, longer intrathyroid half life Metabolised in liver Excreted in urine

Thioamides : Adverse Effects Due to Overtreatment: Hypothyroidism, goiter Important side effects: Gastrointestinal intolerance, skin rashes, joint pain Infrequent side effects: Loss or graying of hair, loss of taste, fever, liver damage Rare but serious: Agranulocytosis

Thioamides : Uses Control Thyrotoxicosis in: Grave’s Disease Toxic Nodular Goiter Can be used as: Definitive therapy Preoperatively Along with 131 I

Ionic Inhibitors Mechanism of Action Inhibits iodide trapping by NIS into the thyroid  T 3 and T 4 not synthesised Toxic and not clinically used these days

Iodine and Iodides Fastest acting thyroid inhibitor Peak effects seen after 10-15 days followed by “thyroid escape” Seen more in multinodular goiter Mechanism of Action (not clear): Inhibition of hormone release- termed as ‘thyroid constipation’ Endocytosis of colloid and proteolysis of thyroglobulin comes to halt. Excess of iodine inhibits its own transport by interfering with expression of NIS Attenuates TSH and cAMP induced thyroid stimulation Rapid and brief intereference with iodination of tyrosil and thyronil residues of Thyroglobulin

Iodine and Iodides: Uses Preoperative preparation Thyroid storm Prophylaxis of endemic goiter As antiseptic

Iodine and Iodide: Adverse Effects Acute Reaction Chronic overdose ( iodism ) Long term use of high doses: Hypothyroidism and goitre Flaring of acne in adolscents Pregnancy/Lactating mothers: Foetal/infantile goitre and hypothyroidism Aggravation of thyrotoxicosis in multinodular goitre

Radioactive Iodine 131 I emits X-rays and β -particles X-rays: tracer studies β -particles: destructive effect on thyroid tissues Mechanism of Action: Concentrated by thyroid, incorporated into colloid  emits radiation from within the follicle  undergo pyknosis and necrosis followed by fibrosis Partial ablation can be achieved

Radioactive Iodine Administered as sodium salt of 131 I dissolved in water and taken orally. Use: Diagnostic: 25-100 mcCurie is given: no damage to thyroid cells occur at this dose Therapeutic: Hyperthyroidism due to Grave’s disease or Toxic nodular goitre Average Dose: 3-6 mCurie ; higher dose for toxic multinodular goitre
Tags